Gsk (GSK) Interest & Investment Income (2009 - 2026)

Gsk (GSK) has 18 years of Interest & Investment Income data on file, last reported at $107.4 million in Q3 2026.

• For the quarter ending Q3 2026, Interest & Investment Income changed N/A year-over-year to $107.4 million; the trailing twelve-month figure through Sep 2026 stood at $353.2 million (changed N/A YoY), and the FY2025 full-year result was $224.8 million, up 44.15% from the prior year.
• Interest & Investment Income was $107.4 million for Q3 2026 at Gsk, up from $77.8 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $138.3 million in Q4 2025 to a low of $9.4 million in Q1 2022.
• A 5-year average of $51.9 million and a median of $40.6 million in 2024 frame the typical range for Interest & Investment Income.
• Across the five-year window, Interest & Investment Income surged 373.01% in 2022 and tumbled 56.39% in 2026, its largest moves.
• Gsk's Interest & Investment Income stood at $32.8 million in 2022, then soared by 134.31% to $77.0 million in 2023, then fell by 6.6% to $71.9 million in 2024, then surged by 92.47% to $138.3 million in 2025, then dropped by 22.36% to $107.4 million in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $107.4 million in Q3 2026, $77.8 million in Q2 2026, and $29.7 million in Q1 2026.